C10AD06 • acipimox • Cardiovascular system | Lipid modifying agents, plain | Nicotinic acid and derivatives
Acipimox is a lipid-lowering medication used to reduce triglyceride and cholesterol levels in the blood, particularly in patients with severe hypertriglyceridemia. It is a derivative of nicotinic acid but has fewer side effects.
Acipimox works by reducing the release of free fatty acids from adipose tissue, leading to decreased triglyceride production in the liver. It is taken orally, usually two to three times a day with meals.
Common side effects include facial flushing, a sensation of warmth, and gastrointestinal disturbances such as nausea or abdominal discomfort. These effects are usually mild and transient.
Patients taking acipimox should be periodically monitored for liver function and blood lipid levels to assess treatment efficacy and prevent potential adverse effects.
Substance: acipimox
Date of last drug list: 01-07-2013
Commercial code: W00210001
Concentration: 250mg
Pharmaceutical form: capsules
Quantity: 30
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.